Transparent source editions

Clinical evidence that can be reviewed

NgMedicare links warnings to maintained source material so pharmacists can inspect the basis for an automated result.

Clinical responsibility: NgMedicare supports pharmacy teams. It does not diagnose, prescribe or replace pharmacist judgement.
Diagram showing a prescription moving through interaction review, a clear pharmacy action and an audit record
One structured workflow from medication review to accountable action.
LatestCurrent source set
LatestNigeria EML included
Role controlledAuthorized pharmacy access
Audit recordedReviewable clinical activity
01

Current source library

The repository currently contains the latest source set, Nigeria Essential Medicines List 2020, NAFDAC Greenbook 2024 material and selected TB/HIV clinical guidance.

02

Source presence is not endorsement

Using a public or licensed clinical source does not mean the issuing organization approves NgMedicare.

03

Edition governance

Clinical leaders should confirm source editions, update schedules and local formulary requirements during implementation.

04

Clinical responsibility

Evidence supports review. It does not replace patient-specific assessment, pharmacist judgement or current specialist guidance.

Questions from pharmacy leaders

Frequently asked questions

Which reference is currently used?

The latest source set.

Is the Nigeria EML included?

The current source library includes the Nigeria Essential Medicines List 2020.

For pharmacy and healthcare organizations

Book a 15-minute Pharmacy Demo

We’ll walk through a real prescription scenario and show how interactions, warnings, and documentation appear in your workflow.

Book a 15-minute Pharmacy Demo

Evidence-backed clinical decision support for pharmacy teams.